Please provide your email address to receive an email when new articles are posted on . Treatment of generalized anxiety disorder with an antidepressant increased the treatment response rate by 41%.

Generalized anxiety disorder affects millions, often trapping sufferers in cycles of fear and isolation that conventional medications barely relieve. At UCSF, neuroscientist Jennifer Mitchell is ...

Please provide your email address to receive an email when new articles are posted on . NEW YORK — One dose of lysergide produced clinical remission of generalized anxiety disorder as soon as 4 weeks ...

The clinical-stage biopharma company Mind Medicine-also known as MindMed MNMD, which recently made headlines regarding its stock, announced it will begin dosing patients within its Phase 2b trial on ...

Millions of Americans with anxiety and depression struggle to find the right medication. The best fit may depend on your ...

Findings showed the 100mcg dose met the primary endpoint demonstrating a statistically significant 7.6-point reduction in HAM-A score at week 4 compared with placebo. The Food and Drug Administration ...

Psychotropic drugs are all the rage now as a potential treatment of brain diseases. Examples are ketamine and psilocybin for depression and PTSD. More recently, a single dose of LSD was found to have ...

Scientists have identified a significant link between low levels of choline and the prevalence of anxiety disorders, ...

People with anxiety disorders have lower levels of choline in their brains, according to research from UC Davis Health.

BrainsWay (BWAY) announced that the FDA has granted a label expansion for the Deep Transcranial Magnetic Stimulation, or Deep TMS, system making ...

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry ...